Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target

Author(s): Jaap Keijer, Dorien A.M. van Dartel

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 15 , 2014

Become EABM
Become Reviewer


Metabolism in cancer cells is reprogrammed. Cancer cells largely depend on glycolysis for ATP production. The metabolic alterations in cancer cells facilitate resistance to cell death as well as biosynthesis of nucleotides and lipids, building blocks for growth. The reprogrammed metabolism is increasingly seen as a target in cancer therapy. This review describes the metabolic reprogramming of cancer cells and illustrates how this is related to cell cycle and apoptosis resistance. Is also describes various scenarios for targeting cancer cell metabolism and highlights options for interventions with nutrition and bioactive food components.

Keywords: Mitochondria, metabolic reprogramming, energy metabolism, targeting metabolism, AMPK, mTOR, polyphenols, apoptosis, ROS, bioactive food components.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [2580 - 2594]
Pages: 15
DOI: 10.2174/13816128113199990483
Price: $65

Article Metrics

PDF: 54